Sign in

CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208623253
Phone
908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
Open-market buys, last 90 days
$99,331
in 1 filing
Open-market sales, last 90 days
$378,930
in 4 filings, $379K under 10b5-1 plans

Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Barber Daniel −$333K President and CEO sold 11% of stake
  2. Daly Richard J +$99K Director 1 filing
  3. Korczynski Sherry −$46K Chief Commercial Officer sold 4% of stake

Reading 92 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-30 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise · Restricted Stock Units −333 0
2020-06-30 Kendall Keith J CEO and President Option exercise +333 639,297
2020-06-30 Kendall Keith J CEO and President Shares withheld for taxes −148 $4.86 $719 639,149
2020-06-30 Kendall Keith J CEO and President Option exercise · Restricted Stock Units −333 0
2020-06-16 BROWN GREGORY B Director Grant or award · Stock Option (Right to Purchase) +14,000 14,000
2020-06-16 Scibetta James S Director Grant or award · Stock Option (Right to Purchase) +14,000 14,000
2020-06-16 Lurker Nancy Director Grant or award · Stock Option (Right to Purchase) +14,000 14,000
2020-06-16 COSTA SANTO J Director Grant or award · Stock Option (Right to Purchase) +14,000 14,000
2020-06-16 BRATTON DOUGLAS K Director Grant or award · Stock Option (Right to Purchase) +14,000 14,000
2020-06-16 Cochran John Director Grant or award · Stock Option (Right to Purchase) +14,000 14,000
2020-06-04 Kendall Keith J CEO and President Sale −50,000 $5.11 $255K 638,964
2020-05-31 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise +14,572 916,685
2020-05-31 Schobel Alexander Mark Chief Innovation/Tech Officer Shares withheld for taxes −4,132 $4.87 $20K 912,553
2020-05-31 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise · Restricted Stock Units −14,572 0
2020-05-31 Kendall Keith J CEO and President Option exercise +14,572 695,456
2020-05-31 Kendall Keith J CEO and President Shares withheld for taxes −6,492 $4.87 $32K 688,964
2020-05-31 Kendall Keith J CEO and President Option exercise · Restricted Stock Units −14,572 0
2020-05-08 Schobel Alexander Mark Chief Innovation/Tech Officer Sale −40,000 $5.00 $200K 902,113
2020-04-27 Schobel Alexander Mark Chief Innovation/Tech Officer Sale −40,000 $4.00 $160K 942,113
2020-04-14 Schobel Alexander Mark Chief Innovation/Tech Officer Sale −40,000 $3.70 $148K 982,113

Page 15 of 15 · 300 trades